Clinical and serological characteristics of nail psoriasis in Indian patients: A cross-sectional study

被引:7
作者
Daulatabad, Deepashree [1 ,2 ]
Grover, Chander [1 ,2 ]
Kashyap, Bineeta [3 ,4 ]
Dhawan, Amit Kumar [1 ,2 ]
Singal, Archana [1 ,2 ]
Kaur, Iqbal R. [3 ,4 ]
机构
[1] Univ Coll Med Sci, Dept Dermatol, New Delhi 110095, India
[2] Univ Coll Med Sci, STD, New Delhi 110095, India
[3] Univ Coll Med Sci, Dept Microbiol, New Delhi, India
[4] Univ Delhi, GTB Hosp, New Delhi 110095, India
关键词
Anti-cyclic citrullinated peptide; nail psoriasis; psoriatic arthritis; rheumatoid factor; CITRULLINATED PEPTIDE ANTIBODIES; C-REACTIVE PROTEIN; RHEUMATOID-ARTHRITIS; SEVERITY; DISEASE; THERAPY; COHORT;
D O I
10.4103/ijdvl.IJDVL_795_16
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Nail involvement in psoriasis is common with a lifetime incidence of 80-90%. It may reflect severity of cutaneous involvement and predict joint disease. Yet it remains, poorly studied and evaluated especially in Indian psoriatic patients. Aim: The present study was undertaken to evaluate clinical and serological profile of nail involvement in psoriasis and to assess quality of life impairment associated with nail involvement in Indian patients. Methods: Consecutive patients with nail psoriasis were assessed for severity of cutaneous disease (psoriasis area severity index score) and nail disease (nail psoriasis severity index score). The impairment in quality of life attributable to nail disease was scored with nail psoriasis quality of life 10 score. All patients were also assessed for joint disease and tested for inflammatory and serological markers as erythrocyte sedimentation rate, C-reactive protein, rheumatoid factor and anti-cyclic citrullinated peptide antibodies. Results: In our cohort of 38 patients with nail psoriasis, 9 had concomitant psoriatic arthritis. The mean psoriasis area severity index was 14.4 +/- 9.6 (range = 0.4-34). The most commonly recorded psoriatic nail changes were pitting (97.4%), onycholysis (94.7%) and subungual hyperkeratosis (89.5%). The mean nail psoriasis severity index score was 83.2 +/- 40.1 ( range = 5-156) and mean nail psoriasis quality of life 10 was 1.1 +/- 0.4. Erythrocyte sedimentation rate and C-reactive protein were raised in 22/38 (57.9%) and 15/38 (39.5%) patients, respectively; rheumatoid factor was positive in 5/38 (13.2%) and anti-cyclic citrullinated peptide antibody was raised in 4/38 (10.5%) patients. Limitations: Small sample size and lack of a control group. Conclusions: In Indian patients with nail psoriasis, severity of nail involvement was found to be poorly correlated with the extent of cutaneous disease. In addition the impact of nail disease on patient's quality of life was found to be minimal. This suggests the need for a quality of life questionnaire suited to the Indian population. Serological markers were raised overall in the study patients and more so in the patients with concomitant arthritis.
引用
收藏
页码:650 / 655
页数:6
相关论文
共 30 条
[1]   Anti-cyclic citrullinated peptide antibodies in psoriasis patients without arthritis [J].
Böckelmann, R ;
Gollnick, H ;
Bonnekoh, B .
ARTHRITIS AND RHEUMATISM, 2006, 54 (05) :1701-1702
[2]  
Bogliolo L, 2005, J RHEUMATOL, V32, P511
[3]   Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis [J].
Candia, Liliana ;
Marquez, Javier ;
Gonzalez, Cesar ;
Santos, Ana Maria ;
Londono, John ;
Valle, Rafael ;
Zabaleta, Jovanny ;
Yaqub, Zunera ;
Espinoza, Luis R. .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2006, 12 (05) :226-229
[4]   Psoriatic arthritis: epidemiological and clinical aspects in a cohort of 1.306 italian patients [J].
Cervini, C. ;
Leardini, G. ;
Mathieu, A. ;
Punzi, L. ;
Scarpa, R. .
REUMATISMO, 2005, 57 (04) :283-290
[5]   C-reactive protein and α2-macroglobulin plasma activity in medium-severe and severe psoriasis [J].
Chodorowska, G ;
Wojnowska, D ;
Juszkiewicz-Borowiec, M .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2004, 18 (02) :180-183
[6]   C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy [J].
Coimbra, S. ;
Oliveira, H. ;
Reis, F. ;
Belo, L. ;
Rocha, S. ;
Quintanilha, A. ;
Figueiredo, A. ;
Teixeira, F. ;
Castro, E. ;
Rocha-Pereira, P. ;
Santos-Silva, A. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 (07) :789-796
[7]   Diagnosis of nail psoriasis: importance of biopsy and histopathology [J].
Grover, C ;
Reddy, BSN ;
Chaturvedi, KU .
BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (06) :1153-1158
[8]   Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis [J].
Inanc, N. ;
Dalkilic, E. ;
Kamali, S. ;
Kasapoglu-Gunal, E. ;
Elbir, Y. ;
Direskeneli, H. ;
Inanc, M. .
CLINICAL RHEUMATOLOGY, 2007, 26 (01) :17-23
[9]   Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy [J].
Jiaravuthisan, Michael M. ;
Sasseville, Denis ;
Vender, Ronald B. ;
Murphy, Francis ;
Muhn, Channy Y. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (01) :1-27
[10]   The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept [J].
Kanelleas, A. ;
Liapi, C. ;
Katoulis, A. ;
Stavropoulos, P. ;
Avgerinou, G. ;
Georgala, S. ;
Economopoulos, T. ;
Stavrianeas, N. G. ;
Katsambas, A. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2011, 36 (08) :845-850